A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Northwell Releases AI-driven Pregnancy Chatbot, Providing Virtual Safety Net to Protect Pregnant Women

Northwell Health today announced the rollout of Northwell Health Pregnancy Chats to obstetrics practices throughout the health system. An artificial intelligence-driven pregnancy chatbot, the customized, conversational platform is a key tool in Northwell’s high-tech and high-touch campaign to reduce maternal morbidity and mortality. The United States has the highest rates of those problems of any of the world’s industrialized nations.

The pregnancy chatbot is both an educational program and a virtual safety net that can identify urgent concerns and ensure speedy help for women during and after pregnancy. It offers weekly informational dialogs that are based on the stage of pregnancy and personalized according to a patient’s self-reported risk factors. Many of the chat’s questions are designed to help patients notice subtle changes sooner than they otherwise might have, which can lead to earlier detection if complications are developing.

The chatbot links seamlessly with a Northwell care management team, enabling prompt escalation to in-person clinical care if a patient’s responses indicate a potentially serious issue, generally directing the patient to connect with her provider. “Red flag” responses trigger an immediate call from a care navigator at Northwell Health Solutions, the health system’s care management arm — or, in some cases, instructions to call 911 or go to the nearest emergency department.

A pilot program at a Northwell obstetric practice showed the tool to be effective. The chatbot was used by 1,632 patients, 96% of whom reported being satisfied or somewhat satisfied with the experience. Critically, the chatbot successfully identified urgent health problems in a handful of users. One woman whose red-flag responses regarding blood pressure prompted a message to call 911 was found to have severe preeclampsia requiring hospitalization. (Preeclampsia is a serious condition involving high blood pressure during pregnancy and can be fatal if not treated.) In another case, during an automated new-parent chat, a woman shared that she had experienced thoughts of harming herself; she reported that she had not shared her symptoms with her provider but felt comfortable acknowledging them to the chatbot because of the feeling of anonymity. The care team reached out immediately and within 24 hours was able to connect the patient with a psychiatrist and other mental health support.

“Northwell Health Pregnancy Chats are both extremely comprehensive and highly individualized and are designed to complement the interactions patients have with their providers,” said Michael Nimaroff, MD, senior vice president of Northwell’s OB/GYN service line and chair of Obstetrics and Gynecology for North Shore University Hospital and Long Island Jewish Medical Center. “It’s a way to ensure women are never without support, whether they’re in a doctor’s office or in their own home.”

The Northwell Health Pregnancy Chats were developed in conjunction with Conversa Health (part of Amwell), a leader in providing automated virtual health. Spanning pregnancy and the first year postpartum, the chats include a health risk assessment and cover maternal and fetal changes throughout pregnancy, blood pressure tracking, prenatal testing, birth plans, lactation support and more. The chatbot will eventually be offered to women receiving pregnancy care at clinics and OB practices throughout Northwell’s catchment area. Sign-up is at no cost to the patient, and chats can be accessed on a patient’s smartphone, tablet or computer.

The tool is an important step in Northwell’s initiative to reduce the country’s maternal mortality rate. In the U.S., 26 out of 100,000 women die during childbirth, compared to 4 out of 100,000 in Italy and Denmark and 9 out of 100,000 in the United Kingdom. The risk is particularly extreme for Black women in the U.S., who are three times more likely than white women to die from pregnancy-related causes. Last year, Northwell launched its Center for Maternal Health to address these risks through a multitude of programs, focusing both on hospital care and community-based wellness efforts.

“Far too many pregnant and birthing people in this country suffer harm or even die because of problems that are entirely preventable. Northwell is committed to doing whatever is necessary to reduce those risks,” said Dawnette Lewis, MD, MPH, director of the Center for Maternal Health. “By bringing together high-tech innovation and high-touch clinical care, the Northwell Health Pregnancy Chats will help keep women and babies safe.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Sachita Shah, Sr. Director, Global Health, Butterfly Network, "Butterfly is proud to continue improving maternal health equity through Phase Two of the largest-scale handheld ultrasound distribution and training ever conducted in Sub-Saharan Africa. South Africa is an emerging market that continues to have disproportionately high rates of maternal mortality and stillbirth. Patients need easier access to antenatal imaging, and clinicians need better capabilities for screening high-risk conditions that lead to disproportionately worse pregnancy outcomes in rural areas in the public sector. Together with CHAI and GUSI, we can tackle this by making ultrasound much more accessible, so high-risk conditions can be identified earlier in care, which is known to improve outcomes.”
The clinical Study will enroll up to 97 patients at up to 12 European investigational sites. Completion of the study is expected this year, and results will support CE mark and pre-market approval submissions reports Vivasure Medical.
Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.

By using this website you agree to accept Medical Device News Magazine Privacy Policy